Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
基本信息
- 批准号:10838849
- 负责人:
- 金额:$ 4.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2024
- 资助国家:美国
- 起止时间:2024-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdultAlcohol abuseAlcohol consumptionAlcoholic beverage heavy drinkerAlcoholsBackBehavior TherapyBrainCerebrumCholineCognitionCognitiveCognitive deficitsCognitive remediationCross-Sectional StudiesEffectivenessFutureGoalsGrantHIVHealthHeavy DrinkingImpaired cognitionInflammationInflammatoryInterleukin-6InterventionIntervention StudiesLinkLiquid substanceLiteratureLongitudinal StudiesMagnetic Resonance SpectroscopyMeasuresMetabolicModelingN-acetylaspartateNeurocognitiveNeuronsOutcomeParticipantPathway interactionsPerformancePersonsPharmacologic SubstancePhysiologicalPlasmaPolypharmacyPopulationQuality of lifeResearchSamplingSecondary toTestingTimeUnited States National Institutes of HealthVulnerable PopulationsWorkadverse outcomealcohol effectbrain healthcognitive benefitscognitive changecognitive performancecohortcomorbiditycytokinedrinkingeffectiveness evaluationfollow-upimprovedinfancyinflammatory markerinsightmedication compliancemyoinositolneuroinflammationreduced alcohol useremediationresponsesecondary analysisstudy populationsystemic inflammatory responsesystemic interventiontimeline
项目摘要
PROJECT SUMMARY/ABSTRACT
Cognitive deficit is prevalent in people living with HIV. Mounting evidence has implicated systemic inflammation
and neuroinflammation in cognitive deficit via HIV-specific mechanisms; however, the cognitive effects of
longitudinal change in inflammation are poorly understood. Preliminary findings from a non-intervention cohort
of adults living with HIV show unexplained cognitive decline across domains over a 2-year period. I
hypothesize that this cognitive decline is associated with an increase in systemic inflammation in
people living with HIV. Thus, to address Aim 1, I will conduct a secondary analysis examining blood plasma
IL-6, CRP, sCD14, and sCD163 as predictors of NIH Toolbox Cognitive Battery change in this cohort. This aim
will provide valuable information on the longitudinal relationship between inflammation and cognition in the
absence of intervention, which may be used as a comparison point for interventional research.
Critically, interventions to reduce systemic inflammation in people living with HIV are in their infancy. Heavy
alcohol use is prevalent among people living with HIV. Alcohol use exacerbates systemic inflammation and
may contribute to increased neuroinflammation, operationalized as disruptions in brain myo-inositol and
choline, in people living with HIV; relatedly, alcohol use is associated with increased cognitive deficit in people
living with HIV. Alcohol reduction is known to partially remediate brain myo-inositol and choline disruptions and
cognitive deficit in seronegative populations. However, the added physiological burden of HIV may reduce the
beneficial impact of alcohol reduction. Having described inflammatory and cognitive change in the absence of
intervention, I will turn to secondary analyses of an interventional study of alcohol reduction to assess its
effectiveness in remediating alcohol-related cognitive deficit in this population. I hypothesize that alcohol
reduction will associate longitudinally with reduced magnetic resonance spectroscopy (MRS) markers
of neuroinflammation and that reduced neuroinflammation will associate longitudinally with improved
cognition in people living with HIV. In Aim 2, I will examine Timeline Follow-Back drinks/month before and
after intervention and HIV serostatus as predictors of brain MRS myo-inositol, choline, and N-acetylaspartate
over 4 time points. In Aim 3, I will assess change in brain MRS myo-inositol, choline, and N-acetylaspartate in
relation to NIH Toolbox Cognitive Battery change over 4 time points. This project, building on the baseline
established by Aim 1, will provide critical insight into the effectiveness of alcohol reduction as an intervention in
this vulnerable population.
项目摘要/摘要
艾滋病毒感染者普遍存在认知缺陷。越来越多的证据表明,
和神经炎症在认知缺陷通过艾滋病毒特异性机制;然而,认知的影响,
炎症的纵向变化知之甚少。非干预队列的初步结果
的成年艾滋病毒感染者在两年的时间里表现出无法解释的认知能力下降。我
假设这种认知能力的下降与全身炎症的增加有关,
艾滋病毒感染者。因此,为了实现目标1,我将进行一项二级分析,
IL-6、CRP、sCD 14和sCD 163是该队列中NIH认知成套测验变化的预测因子。这一目标
将提供有价值的信息,炎症和认知之间的纵向关系,
缺乏干预,这可以作为干预性研究的比较点。
至关重要的是,减少艾滋病毒感染者全身炎症的干预措施尚处于起步阶段。重
在艾滋病毒感染者中,酗酒很普遍。酒精使用会加剧全身炎症,
可能导致神经炎症增加,可操作为脑肌醇的破坏,
胆碱,在艾滋病毒感染者中;相关地,酒精使用与人们认知缺陷的增加有关
艾滋病毒携带者已知减少酒精可部分修复脑肌醇和胆碱中断,
血清反应阴性人群的认知缺陷。然而,增加的HIV生理负担可能会减少
减少酒精的有益影响。在描述了炎症和认知变化,
干预,我将转向二次分析的干预性研究减少酒精,以评估其
在这一人群中治疗酒精相关认知缺陷的有效性。我假设酒精
减少将与纵向减少的磁共振波谱(MRS)标记物相关
减少的神经炎症将与改善的神经炎症纵向相关,
艾滋病毒感染者的认知能力。在目标2中,我将检查时间轴后续饮料/月之前,
干预后和HIV血清状态作为脑MRS肌醇、胆碱和N-乙酰天冬氨酸的预测因子
超过4个时间点。在目标3中,我将评估脑MRS肌醇,胆碱和N-乙酰天冬氨酸的变化,
4个时间点与NIH认知成套测验变化的关系。这个项目建立在
由目标1建立的,将为减少酒精作为干预措施的有效性提供重要的见解,
这个弱势群体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark K Britton其他文献
Mark K Britton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.19万 - 项目类别:
Research Grant